Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and possible pharmacologic
1Cardiology Division, University of Texas Southwestern Medical Center, Dallas 75235-9047.
Cardiovascular Drugs and Therapy
|October 1, 1990
Summary
Left ventricular remodeling after myocardial infarction leads to heart failure. Early interventions with nitroglycerin or captopril show promise in mitigating this process.
Area of Science:
- Cardiology
- Pathophysiology
- Pharmacology
Background:
- Left ventricular remodeling and dilatation following myocardial infarction are key precursors to congestive heart failure.
- This process begins within 24 hours post-infarction and can persist for years, affecting both infarcted and non-infarcted myocardial regions.
Purpose of the Study:
- To elucidate the mechanisms of left ventricular remodeling post-myocardial infarction.
- To explore potential therapeutic strategies to ameliorate cardiac dysfunction resulting from this remodeling.
Main Methods:
- The study reviews existing literature on the pathophysiology of post-myocardial infarction remodeling.
- It examines the cellular and molecular changes involved in left ventricular wall thinning, chamber dilatation, and compensatory hypertrophy.
- It discusses the role of neurohormonal systems in the progression of cardiac dysfunction.
Main Results:
- Left ventricular remodeling involves wall thinning, chamber dilatation, and hypertrophy, contributing to pump dysfunction.
- Dysfunctional hypertrophy may result from architectural changes and altered adrenergic or renin-angiotensin systems.
- Early data suggest nitroglycerin and captopril may attenuate the remodeling process.
Conclusions:
- Left ventricular remodeling is a critical determinant of late congestive heart failure development.
- Pharmacological interventions targeting specific pathways may offer a therapeutic avenue to prevent or reverse adverse cardiac remodeling.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
10:18Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...